Graham Capital Management, L.P. Collegium Pharmaceutical, Inc Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 17,341 shares of COLL stock, worth $557,686. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,341
Previous 12,246
41.61%
Holding current value
$557,686
Previous $475,000
17.47%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding COLL
# of Institutions
250Shares Held
40.5MCall Options Held
84.2KPut Options Held
19.6K-
Black Rock Inc. New York, NY5.79MShares$186 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$110 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$84.7 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$76.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$75 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.1B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...